Diuretics DSA II Flashcards
osmotic agent pharmacy
given IV
- excreted in filtrate (30-60 mins)
- promotes water retention - proximal tubule and descending loop
- oppose ADH in collecting tubule
osmotic agent toxicity
extracellular volume expansion
-extracts water from cells prior to diuresis, leads to expansion of extracellular volume and hyponatremia
osmotic agent contraindication
renal disease, dehyration, pulmonary edema
osmotic agent clinical use
urinary excretion of toxic substance
- reduces intracranial and IOP
- use for prevention of ARF not reccommended
ADH agonists
increased water reabsorption
- vasopressin and desmopressin
- mediate vasoconstriction of vasc. smooth m and increase water permeability in collecting tubule
clinical use ADH agonists
diabetes insipidus, polyuria, polydipsia, hypernatremia, nocturnal uresis
ADH antagonists
SIADH, heart failure
-conivaptan and tolvaptan
demeclocycline
ADH antagonist
-not used - high renal failure incidence
tolvaptan
V2 receptor selectivity
conivaptan
antagonist at V1a and V2 receptors
toxicity of ADH antagonists
hypernatremia
nephrogenic diabetes insipidus
loop and thiazide combo
when acting alone doesn’t work
-more than an additive diuretic response
-thiazides mild natriuresis, blocked in increased thick ascending absorption - combo blocks Na reabsorption
>all three segments - PCT, ascending loop, DCT
metolazone
thiazide diuretic
-often used in COMBO
combination use
not recommended for outpatient
-severe diuresis
K-sparing combo
with loop and thiazide agents
-to control hypokalemia